Innoviva, Inc. (INVA) is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies to treat respiratory diseases and other medical conditions. Founded in 1996, Innoviva aims to improve the quality of life for patients through advanced therapeutic solutions. The company leverages strategic collaborations and partnerships to enhance its product pipeline and expand its market presence.
Innoviva’s key products include Breztri Aerosphere, an inhalation aerosol for the treatment of chronic obstructive pulmonary disease (COPD), and INVA-811, a novel antibiotic in development for the treatment of serious bacterial infections. The company has a diverse portfolio of products that target respiratory and infectious diseases, with a commitment to advancing therapies that address unmet medical needs.
The main drivers of growth for Innoviva include the increasing prevalence of respiratory diseases, such as asthma and COPD, as well as the ongoing demand for effective antibiotics to combat drug-resistant infections. As healthcare providers and patients seek more effective treatment options, Innoviva’s focus on research and development positions it well to capture opportunities in these growing markets. Additionally, the company’s partnerships with other biopharmaceutical firms help to accelerate the development and commercialization of its product candidates. Learn more at Innoviva, Inc..
Click The Image For Current Live Chart
Backtesting a stock can provide investors with critical statistical data. These results give you an informed perspective on how a stock trades within your chosen buying and selling method of analysis. The definition of trade expectancy is defined as: trade expectancy = (probability of win * average win) – (probability of loss * average loss). If the calculation returns a positive number, a trader should make money over time.
The average percentage gained on positive, money making trades was 23.24%. While the average percent loss on money losing trades was 4.22%.
Trade expectancy includes both winners and losers. Trade expectancy is displayed as a percentage. This backtest displays the dollar value, percentage, annual trade expectancy, and annual percent. Annual expectancy is the trade expectancy percentage multiplied by the number of trades per year.
The Trade expectancy % for INVA over the past year is 14.09%. The number of trades generated per year was 3 giving an Annual Trade Expectancy of 42.27%
The average days in a trade is 49 and the average days between trades is 13.
With any method of analysis that uses past performance, it can be said that past performance is not indication of future performance. What is does provide is a probabilistic look at a stock’s price activity characteristics over time.
Click To Download Report and Backtest Data 